Articles From: Stock futures waver ahead of jobless claims, Yellen to UPDATE: Stock futures fall; eyes on Pfizer, AT&T, Fed speakers


2014/5/8
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stock futures struggled for direction before a second day of congressional testimony by Federal Reserve Chairwoman Janet Yellen, and ahead of a possible pullback in weekly jobless claim after an unexpected spike higher.
Sign-up for Stock futures waver ahead of jobless claims, Yellen investment picks
2014/4/30
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks gained Wednesday, as a jump in shares of oil major Royal Dutch Shell PLC helped the FTSE 100 score a win on the last trading day of the month.
Sign-up for UPDATE: U.K. stocks score monthly gain; Shell rises investment picks
2014/4/30
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks slipped Wednesday, with losses for shares of BNP Paribas SA and GlaxoSmithKline PLC among those tugging the pan-European equity benchmark back from a strong gain logged in the previous session.
Sign-up for UPDATE: European stocks ease as BNP, Glaxo lose ground investment picks
2014/4/30
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks gained Wednesday, with a jump in shares of oil major Royal Dutch Shell PLC helping the FTSE 100 move toward a win on the last trading day of the month.
Sign-up for UPDATE: U.K. stocks reach for monthly gain; Shell rises investment picks
2014/4/30
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks slipped Wednesday, with losses for shares of BNP Paribas SA and Standard Life PLC among those pulling the pan-European equity benchmark back from a strong gain logged in the previous session.
Sign-up for UPDATE: European stocks ease as BNP, Standard Life lose ground investment picks
2014/4/30
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks gained Wednesday, with a bump up in shares of oil major Royal Dutch Shell PLC helping the FTSE 100 move toward a win on the last trading day of the month.
Sign-up for U.K. stocks reach for monthly gain; Shell rises investment picks
2014/5/13
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European equities rose Tuesday, with shares of Germany's ThyssenKrupp AG climbing on an improved earnings outlook, but the pan-European index came off session highs after a downbeat consumer sentiment reading from Europe's largest economy.
Sign-up for UPDATE: Europe stocks advance, but German data disappoint investment picks
2014/5/13
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Stocks in Europe moved higher Tuesday, with the pan-European benchmark hanging at a six-year high in part as Germany's ThyssenKrupp AG shares jumped on an improved earnings outlook.
Sign-up for Europe stocks extend push into six-year high investment picks
2014/5/13
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks pared gains Tuesday, moving in line with a broader pullback in Europe after a disappointing sentiment survey, but AstraZeneca PLC shares pushed higher as Pfizer Inc. made its case for a takeover of the drug maker.
Sign-up for U.K. stocks off highs, but AstraZeneca holds gain investment picks
2014/5/7
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stocks futures swung higher Wednesday as investors waited to hear congressional testimony from Federal Reserve Chairwoman Janet Yellen about monetary policy and the economy, while the market also looked to assess a possible decline in productivity for the first quarter.
Sign-up for UPDATE: U.S. stock futures turn higher; Yellen testimony on tap investment picks
2014/5/7
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stocks futures slipped Wednesday as investors waited to hear congressional testimony from Federal Reserve Chairwoman Janet Yellen about monetary policy and the economy, while the market also looked to assess a possible decline in productivity for the first quarter.
Sign-up for UPDATE: U.S. stock futures slip with Yellen testimony on tap investment picks
2014/5/7
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stocks futures slipped Wednesday as investors waited to hear congressional testimony from Federal Reserve Chairwoman Janet Yellen about monetary policy and the economy, while the market also looked to assess a possible decline in productivity for the first quarter.
Sign-up for U.S. stock futures slip with Yellen testimony on tap investment picks
2014/5/6
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stock futures pared gains Tuesday ahead of trade data, as investors eye deal news from Merck & Co.
Sign-up for UPDATE: U.S. stock futures pare gains; Merck in focus investment picks
2014/5/6
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stock futures edged higher Tuesday, following on from Wall Street's gains in the previous session, but investors may be grappling for a focus with just trade data coming due ahead of the open.
Sign-up for U.S. stock futures up ahead of trade data investment picks
2014/5/5
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Monday as worries about a ramp-up in violence in Ukraine and persistently low inflation in the euro zone hung over the market.
Sign-up for UPDATE: Europe stocks decline; SAP hit by executive's departure investment picks
2014/5/5
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Monday as worries about a ramp-up in violence in Ukraine and persistently low inflation in the euro zone hung over the market.
Sign-up for UPDATE: Europe stocks drag; SAP hit by executive's departure investment picks
2014/5/14
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks eked out a small gain Wednesday after the Bank of England signaled that it's not quite ready to increase the country's key interest rate.
Sign-up for UPDATE: U.K. stocks edge up; rate hike appears on hold investment picks
2014/5/14
By Carla Mozee, MarketWatch LONDON (MarketWatch)--European stocks slipped Wednesday, with a pull back in shares of broadcaster Mediaset SpA weighing on the benchmark index after it reached a six-year high.
Sign-up for UPDATE: European stocks step back from multiyear highs investment picks
2014/5/14
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks narrowed losses Wednesday after the Bank of England signaled that it's not quite ready to increase the country's key interest rate.
Sign-up for UPDATE: U.K. stocks narrow losses as rate hike appears on hold investment picks
2014/5/14
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks declined Wednesday, edging back from a multiyear high as investors looked to an inflation report that may provide signals as to when the Bank of England will begin to raise interest rates.
Sign-up for U.K. stocks slip ahead of monthly inflation report investment picks
2014/5/14
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks slipped Wednesday, with the region's equity benchmark stepping back from gains that pushed it to a multiyear high in the previous session.
Sign-up for European stocks step back from multiyear highs investment picks
2014/5/19
By Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- U.S. stock futures dropped Monday, with investors set to assess a slate of deal developments, including the rejection of Pfizer Inc.'s bid to buy drug maker AstraZeneca PLC, while waiting for two Federal Reserve officials to talk about monetary policy.
Sign-up for UPDATE: U.S. stock futures fall; Pfizer, AT&T in focus investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks gained Monday, as AstraZeneca PLC shares soared after Pfizer Inc. said it's tried again to court the drug maker into a multibillion-dollar takeover, but investors pulled down shares of Siemens AG as the company moved to buy a unit from France's Alstom SA.
Sign-up for UPDATE: European shares up; AstraZeneca surges on M&A prospect investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- AstraZeneca PLC shares fronted gains for U.K. equities Monday, bolstered by renewed prospects for a Pfizer Inc. takeover of the British drug maker.
Sign-up for AstraZeneca jumps, leading U.K. stocks higher investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- AstraZeneca PLC shares led gains for U.K. equities Monday, bolstered by renewed prospects for a Pfizer Inc. takeover of the British drug maker.
Sign-up for UPDATE: AstraZeneca jumps, leading U.K. stocks higher investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Stocks in the U.K. rose Tuesday, headed by Shire PLC on speculation the drug maker may land an acquisition offer, and the market held its ground after quarterly economic growth in the U.K. came in at a slower rate than anticipated.
Sign-up for Shire leads U.K. market higher on takeover speculation investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks rose Monday, with AstraZeneca PLC shares moving higher after Pfizer Inc. said it is trying again to court the drug maker into a multibillion-dollar takeover, but investors pulled down shares of Siemens AG as the company moved to buy a unit from France's Alstom SA.
Sign-up for European shares up; AstraZeneca surges on M&A prospects investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks rose Monday, with AstraZeneca PLC shares moving higher after Pfizer Inc. said it is trying again to court the drug maker into a multibillion-dollar takeover, but investors pulled down shares of Siemens AG as the company moved to buy a unit from France's Alstom SA.
Sign-up for UPDATE: European shares up; AstraZeneca surges on M&A prospects investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Stocks in the U.K. rose Tuesday, with the FTSE 100 benefitting from gains in BP PLC shares, but Shire PLC was knocked off the list of advancers as prospects of a takeover offer for the biopharmaceutical firm dimmed.
Sign-up for UPDATE: U.K. stocks advance, but Shire loses grip of gains investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stock futures dropped Monday, with investors set to assess a slate of deal developments, including the rejection of Pfizer Inc.'s bid to buy drug maker AstraZeneca PLC, while waiting for two Federal Reserve officials to talk about monetary policy.
Sign-up for UPDATE: Stock futures fall; eyes on Pfizer, AT&T, Fed speakers investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Stock futures waver ahead of jobless claims, Yellen to UPDATE: Stock futures fall; eyes on Pfizer, AT&T, Fed speakers
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry